APO-MEROPENEM meropenem (as trihydrate) 1000 mg powder for injection vial

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

meropenem trihydrate, Quantity: 1141 mg (Equivalent: meropenem, Qty 1000 mg)

Mevcut itibaren:

Arrotex Pharmaceuticals Pty Ltd

INN (International Adı):

Meropenem trihydrate

Farmasötik formu:

Injection, powder for

Kompozisyon:

Excipient Ingredients: sodium carbonate

Uygulama yolu:

Intravenous

Paketteki üniteler:

10 vials

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

Meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: Community acquired lower respiratory tract infection; Hospital acquired lower respiratory tract infection; Complicated urinary tract infection; Febrile neutropenia; Intra-abdominal and gynaecological (poly microbial) infections; Complicated skin and skin structure infections; Meningitis; Septicaemia

Ürün özeti:

Visual Identification: White to slightly yellow powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2014-12-18